Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy
AUTOR(ES)
Chouaib, Salem
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=151911Documentos Relacionados
- Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
- Integrating SNOMED CT into the UMLS: An Exploration of Different Views of Synonymy and Quality of Editing
- Outcomes of a quality improvement project integrating mental health into primary care
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- Immunotherapy of Trypanosoma cruzi Infection with DNA Vaccines in Mice